ICU Medical (NASDAQ:ICUI) Downgraded to “Hold” Rating by Wall Street Zen

ICU Medical (NASDAQ:ICUI) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

Several other equities analysts have also weighed in on the stock. KeyCorp increased their price target on shares of ICU Medical from $173.00 to $175.00 and gave the company an “overweight” rating in a research report on Friday, November 7th. Weiss Ratings reiterated a “sell (d-)” rating on shares of ICU Medical in a research note on Thursday, January 22nd. Finally, Piper Sandler raised their price target on shares of ICU Medical from $153.00 to $172.00 and gave the stock an “overweight” rating in a research note on Friday, November 7th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $175.67.

ICU Medical Stock Performance

Shares of ICUI opened at $154.16 on Friday. The stock has a 50 day moving average of $148.59 and a 200 day moving average of $134.41. The company has a market capitalization of $3.81 billion, a price-to-earnings ratio of -497.27 and a beta of 0.79. ICU Medical has a 12 month low of $107.00 and a 12 month high of $165.17. The company has a current ratio of 2.45, a quick ratio of 1.19 and a debt-to-equity ratio of 0.62.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $2.03 earnings per share for the quarter, topping the consensus estimate of $1.43 by $0.60. The business had revenue of $533.30 million for the quarter, compared to analysts’ expectations of $511.46 million. ICU Medical had a positive return on equity of 7.71% and a negative net margin of 0.32%.The business’s revenue was down 8.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.59 earnings per share. As a group, sell-side analysts forecast that ICU Medical will post 4.11 earnings per share for the current year.

Insider Activity at ICU Medical

In related news, VP Virginia Ruth Sanzone sold 930 shares of the company’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $142.34, for a total transaction of $132,376.20. Following the sale, the vice president directly owned 5,456 shares in the company, valued at approximately $776,607.04. This represents a 14.56% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Elisha W. Finney sold 1,285 shares of ICU Medical stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $140.42, for a total transaction of $180,439.70. Following the completion of the transaction, the director owned 3,995 shares of the company’s stock, valued at $560,977.90. This represents a 24.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Cullen Frost Bankers Inc. bought a new stake in ICU Medical during the second quarter valued at $38,000. SJS Investment Consulting Inc. boosted its position in shares of ICU Medical by 41,000.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 411 shares of the medical instruments supplier’s stock valued at $49,000 after acquiring an additional 410 shares during the last quarter. Covestor Ltd grew its holdings in shares of ICU Medical by 70.7% during the third quarter. Covestor Ltd now owns 570 shares of the medical instruments supplier’s stock worth $68,000 after purchasing an additional 236 shares in the last quarter. Strs Ohio increased its position in shares of ICU Medical by 60.0% in the fourth quarter. Strs Ohio now owns 800 shares of the medical instruments supplier’s stock worth $114,000 after purchasing an additional 300 shares during the last quarter. Finally, Blue Trust Inc. raised its stake in ICU Medical by 17.6% in the second quarter. Blue Trust Inc. now owns 942 shares of the medical instruments supplier’s stock valued at $124,000 after purchasing an additional 141 shares in the last quarter. Institutional investors own 96.10% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.